The expressions of KLF6 and TGFβ were found to be augmented during the progression of NAFLD to NASH, thereby corroborating the roles of the KLF6-TGFβ axis in the development and progression of liver fibrosis and steatosis [134]. Here, KLF6 is linked to metabolic dysfunction-associated steatohepatitis.